Journal profile
Drug Analytical Research
ISSN 2527-2616 · Universidade Federal do Rio Grande do Sul · Brazil
Drug Analytical Research: diamond open access (no APC); no APC; review about 10 weeks (community reports); 15 articles in 2025.
Scope
Aims, scope and focus
Drug Analytical Research is published by Universidade Federal do Rio Grande do Sul. By OpenAlex counts of its recent articles, its largest topics are Analytical Methods in Pharmaceuticals, Pharmaceutical Quality and Counterfeiting and Forensic Toxicology and Drug Analysis, together about 50% of its articles. Its main subfields are Analytical Chemistry. (generated from OpenAlex topic counts and CAS ranking data)
Drug Analytical Research is a scientific journal published by the School of Pharmacy at the Federal University of Rio Grande do Sul (UFRGS). It is a semiannual, open-access journal dedicated to the publication of both original and review articles in all areas of analytical and bioanalytical chemistry applied to pharmaceutical sciences. It includes the development and the application of analytical methodology focusing on quality control of drugs/medicines, pharmaceutical technology, natural products, drug purity and stability studies, pharmacokinetics, analytical biochemistry and toxicology.
From the journal's Aims & Scope
Editor-in-chief Cássia Virginia GarciaPublisher website
Editorial board by country: none in mainland China; most named Brazil 19, United States 1, Italy 1, Argentina 1, Chile 1 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Methods in PharmaceuticalsChemistry31.2%
- Pharmaceutical Quality and CounterfeitingMedicine11.2%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics7.7%
- Analytical Chemistry and ChromatographyChemistry7.7%
- Analytical chemistry methods developmentChemistry4.4%
- Pesticide Residue Analysis and SafetyAgricultural and Biological Sciences4.4%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics2.7%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Google Scholar, Scilit, Latindex, Semantic ScholarPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 11OpenAlex ·
- i10-index
- 14OpenAlex ·
- 2-year mean citedness
- 0.77OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 145 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 7 | 7 | 68 |
| 2025 | 15 | 15 | 99 |
| 2024 | 21 | 21 | 90 |
| 2023 | 10 | 10 | 122 |
| 2022 | 14 | 14 | 82 |
| 2021 | 27 | 27 | 61 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 6,000 words
- Reference style
- Vancouver
Article types accepted4, with length limits
- original articlect their manuscripts before submission. Original Articles should contain no more than 25 pages and not exceed 6,000 words. For Review Articles, until 9,000 word…main text ≤ 6,000 words
- original articlesORIGINAL ARTICLESLength not stated
- review article5 pages and not exceed 6,000 words. For Review Articles, until 9,000 words will be accepted. Exceptions may be accepted after decisionmain text ≤ 9,000 words
- review articlesREVIEW ARTICLESLength not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Data availability, Publication ethics, License & copyright, Peer review
- AI use
AI use must be disclosed in the Methods section; AI-generated content is discouraged unless part of formal research design and not permitted without clear description of the tool name. Model summary
Authors must publicize any use of generative AI and AI-assisted technologies in the elaboration of manuscript by adding a statement within the Methods section of their manuscript. Content created by artificial intelligence is discouraged, unless part of formal research design and is not permitted without clear description of the name of the tool.
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Conflicts of interest must be declared, or a statement of no conflicts provided. Model summary
Authors are required to disclose any potential competing interests during submission. This includes financial or commercial interests (e.g., patent ownership, consulting fees, speaker fees, employment with a company). This disclosure should be made for each author. If no competing interests exist, the following statement should be included: "The authors declare no conflicts of interest related to …
Source ↗Publisher website ·- Data availability
Names and addresses are used exclusively for services provided by the publication and not shared with third parties. Model summary
Names and addresses informed here will be used exclusively for the services provided by this publication, and will not be made available for other purposes or to third parties.
Source ↗Publisher website ·- Publication ethics
Studies on humans or animals require prior ethics approval from an appropriate institutional review body. Model summary
Every experimental study on humans or animals must be proven to have the prior ethics approval of the appropriate institutional review body.
Source ↗Publisher website ·- License & copyright Copyright Notice
Articles are licensed under CC BY-NC-SA 4.0, permitting reading, downloading, copying, distribution, printing, searching, linking, and other lawful uses without prior permission. Model summary
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journ…
Source ↗Publisher website ·- Peer review Peer Review Process
Submitted original and review articles will undergo evaluation by two prominent researchers recognized in the field, in single-blind peer review. The evaluation criteria prioritize innovation, originality, relevance, and the contribution of the manuscript to the scientific community. Reviewers are given up to 30 days from submission to provide their feedback.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Universidade Federal do Rio Grande do Sul
- Country or region
- Brazil
- Language
- English
- ISSN
- 2527-2616
- Latest issue on the website
- Volume 10, Issue 1 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Drug Analytical Research
How long does peer review take at Drug Analytical Research?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Drug Analytical Research?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 6,000 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Drug Analytical Research based?
Of the 23 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Brazil (19), United States (1) and Italy (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Drug Analytical Research?
According to LetPub and DOAJ records, Drug Analytical Research is indexed in DOAJ.
Is Drug Analytical Research open access, and what is the APC?
Drug Analytical Research is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .